EG19346A - Process for preparing of antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives - Google Patents

Process for preparing of antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives

Info

Publication number
EG19346A
EG19346A EG65887A EG65887A EG19346A EG 19346 A EG19346 A EG 19346A EG 65887 A EG65887 A EG 65887A EG 65887 A EG65887 A EG 65887A EG 19346 A EG19346 A EG 19346A
Authority
EG
Egypt
Prior art keywords
antiviral
preparing
pyrimidine derivatives
phosphonomethoxyalkylene
purine
Prior art date
Application number
EG65887A
Other languages
English (en)
Inventor
Robert R Webb
Original Assignee
Acad Of Science Czech Republic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26812069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG19346(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acad Of Science Czech Republic filed Critical Acad Of Science Czech Republic
Application granted granted Critical
Publication of EG19346A publication Critical patent/EG19346A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EG65887A 1986-11-18 1987-11-17 Process for preparing of antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives EG19346A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93211286A 1986-11-18 1986-11-18
US11434087A 1987-11-04 1987-11-04

Publications (1)

Publication Number Publication Date
EG19346A true EG19346A (en) 1995-01-31

Family

ID=26812069

Family Applications (1)

Application Number Title Priority Date Filing Date
EG65887A EG19346A (en) 1986-11-18 1987-11-17 Process for preparing of antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives

Country Status (12)

Country Link
EP (1) EP0269947B2 (xx)
JP (1) JP2593895B2 (xx)
KR (1) KR950009195B1 (xx)
AU (1) AU613592B2 (xx)
CA (1) CA1339780C (xx)
DE (1) DE3780581T3 (xx)
DK (1) DK170049B1 (xx)
EG (1) EG19346A (xx)
ES (1) ES2033774T5 (xx)
GR (2) GR3005256T3 (xx)
IL (1) IL84477A (xx)
NZ (1) NZ222553A (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) * 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
EP0338168A1 (en) * 1988-04-19 1989-10-25 Merrell Dow Pharmaceuticals Inc. Phosphonoalkylpurine derivatives
US5266722A (en) * 1988-11-09 1993-11-30 W. R. Grace & Co.-Conn. Polyether bis-phosphonic acid compounds
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
ATE124050T1 (de) * 1990-04-20 1995-07-15 Acad Of Science Czech Republic Chirale 2-(phosphonomethoxy)propyl-guanine als antivirale agentien.
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
SK280313B6 (sk) * 1990-04-24 1999-11-08 �Stav Organick� Chemie A Biochemie Av �R N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov
EP0481214B1 (en) * 1990-09-14 1998-06-24 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Prodrugs of phosphonates
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
ATE151432T1 (de) * 1991-10-11 1997-04-15 Acad Of Science Czech Republic Antivirale acyclische phosphonomethoxyalkyl substituierte, alkenyl und alkynyl purin und pyrimidin-derivate
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
KR100386685B1 (ko) * 1993-09-17 2003-12-31 길리애드 사이언시즈, 인코포레이티드 뉴클레오타이드동족체류
US5798340A (en) * 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5656745A (en) * 1993-09-17 1997-08-12 Gilead Sciences, Inc. Nucleotide analogs
IT1270008B (it) * 1994-09-23 1997-04-16 Ist Superiore Sanita Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US5717095A (en) * 1995-12-29 1998-02-10 Gilead Sciences, Inc. Nucleotide analogs
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
CA2261619C (en) * 1996-07-26 2006-05-23 Gilead Sciences, Inc. Nucleotide analogs
AU740264C (en) * 1997-09-11 2002-06-06 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
CA2452036C (en) 2001-06-29 2009-09-29 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
US7388002B2 (en) 2001-11-14 2008-06-17 Biocryst Pharmaceuticals, Inc. Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
WO2003087298A2 (en) * 2001-11-14 2003-10-23 Biocryst Pharmaceuticals, Inc. Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
KR20090053867A (ko) 2003-01-14 2009-05-27 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
US7371852B2 (en) 2003-01-22 2008-05-13 Serenex, Inc. Alkyl-linked nucleotide compositions
EA011948B1 (ru) 2003-06-16 2009-06-30 Инститьют Оф Оргэник Кемистри Энд Байокемистри, Экэдеми Оф Сайэнс Оф Зе Чек Рипаблик Фосфонатзамещенные пиримидиновые соединения (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции
AU2004260789B2 (en) 2003-07-30 2011-06-30 Gilead Sciences, Inc. Nucleobase phosphonate analogs for antiviral treatment
WO2005090370A1 (en) 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
MX2013006127A (es) 2010-12-10 2013-09-26 Sigmapharm Lab Llc Composiciones sumamente estables de analogos nucleotidicoas oralmente activos o profarmacos analogos nucleotidicos oralmente activos.
CA2857490C (en) 2011-12-22 2020-03-31 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
CN103665043B (zh) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 一种替诺福韦前药及其在医药上的应用
RS63250B1 (sr) * 2014-09-15 2022-06-30 Univ California Nukleotidni analozi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) * 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
ES2033774T3 (es) 1993-04-01
DE3780581T2 (de) 1992-12-17
AU613592B2 (en) 1991-08-08
JPS63170388A (ja) 1988-07-14
NZ222553A (en) 1991-07-26
DK604087A (da) 1988-05-19
IL84477A (en) 1995-12-08
CA1339780C (en) 1998-03-24
DE3780581D1 (de) 1992-08-27
KR880006256A (ko) 1988-07-22
EP0269947B1 (en) 1992-07-22
ES2033774T5 (es) 1997-03-16
EP0269947B2 (en) 1996-10-16
GR3005256T3 (en) 1993-05-24
KR950009195B1 (ko) 1995-08-16
EP0269947A1 (en) 1988-06-08
AU8125087A (en) 1988-05-19
DK170049B1 (da) 1995-05-08
GR3021389T3 (en) 1997-01-31
DK604087D0 (da) 1987-11-17
DE3780581T3 (de) 1997-06-05
JP2593895B2 (ja) 1997-03-26

Similar Documents

Publication Publication Date Title
EG19346A (en) Process for preparing of antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
PL288403A1 (en) Method of obtaining enantiomeric analogues of purine nucleosides and method of obtaining novel pyrimidine derivatives
LTIP269A (en) Method of preparing pyrimidine derivatives
EG18734A (en) Process for preparing of bis.(hydroxymethyl) cyclobutyl purines and pyrimidines
CS724285A2 (en) Process for preparing derivatives of purine
PL276697A1 (en) Method of obtaining novel adenosine derivatives
PT85551A (en) Process for the preparation of antiviral pyrimidine derivatives and of pharmaceutical compositions containing the same
CS151787A2 (en) Process for preparing carbocyclic nucleosides of purine
GR871666B (en) Heteroaromatic derivatives of adenosine
NZ226644A (en) Process for preparation of purine derivatives and precursors therefor
HU904110D0 (en) Process for producing pyrimidine derivatives
LTIP539A (en) Inhibitors of purine nucleoside phosphorylase and process for preparing thereof
HU900896D0 (en) Process for preparation of antiviral benzodiazepine derivatives
HUT40131A (en) Process for preparing purine derivatives
YU199688A (en) Process for obtaining purine derivatives
HUT45077A (en) Process for producing pyrimidine derivatives
EG18301A (en) Process for preparing of 4(3h)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivatives
YU93288A (en) Process for producing pyrimidine derivatives
HUT45078A (en) Process for producing pyrimidine derivatives
HUT45528A (en) Process for producing purine derivatives and pharmaceutics comprising such compounds
NZ224958A (en) Process for preparation of purine derivatives and intermediate pyrimidines
PT78769A (en) Process for preparing (s)-9-(2,3-dihydroxy-1-propoxymethyl)guanine and derivatives thereof useful as antiviral agents
GR872084B (en) Preparation process of pyrimidine derivatives
CS89588A2 (en) Method of carbocyclic purine nicleotides preparation
EP0564006A3 (en) Process for preparing purine derivatives and novel purine derivatives